Coloplast A/S (OTCMKTS:CLPBY) Issues Quarterly Earnings Results

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.08 earnings per share for the quarter, reports. The business had revenue of $1.02 billion for the quarter. Coloplast A/S had a net margin of 18.89% and a return on equity of 31.39%. Coloplast A/S updated its FY 2025 guidance to EPS.

Coloplast A/S Price Performance

OTCMKTS CLPBY opened at $13.28 on Friday. The business’s fifty day moving average is $13.22 and its 200 day moving average is $12.84. Coloplast A/S has a fifty-two week low of $9.90 and a fifty-two week high of $14.34. The company has a current ratio of 0.85, a quick ratio of 0.56 and a debt-to-equity ratio of 1.00.

About Coloplast A/S

(Get Free Report)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.

See Also

Earnings History for Coloplast A/S (OTCMKTS:CLPBY)

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.